Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Real-world Experience With Sunitinib Treatment in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to Risk Score - Clinical Genitourinary Cancer
Sunitinib: the antiangiogenic effects and beyond | OTT
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial - The Lancet
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
ASCO GU 2018: Phase III Trial of Adjuvant Sunitinib in Patients with High-risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features | Journal of Clinical Oncology
Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence | Semantic Scholar
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial - The Lancet Oncology
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial - The Lancet Oncology
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Efficacy results of Phase III clinical trials comparing immune... | Download Scientific Diagram
Sunitinib maleate | Nature Reviews Drug Discovery
Sunitinib ongoing clinical trials. | Download Scientific Diagram
Selected clinical trials of sunitinib. GIST, gastrointestinal stromal... | Download Table
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial - European Journal of Cancer
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial - European Journal of Cancer
Clinical trials of Sunitinib in patients with thyroid cancer. | Download Table
Sunitinib for Gastrointestinal Stromal Tumors Clinical Trial | Power
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma | NEJM
Clinical benefit of sunitinib in the phase I/II trial in imatinib... | Download Table
Sunitinib shows efficacy in pheochromocytoma and paraganglioma
Clinical trials with presurgical sunitinib. | Download Scientific Diagram
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials - European Journal of Cancer
